New cancer clinical trial: HIPEC After Initial CRS in Patients Who Have Received NACT

Published on: May 30, 2018 at 12:00PM
Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Intervention:   Drug: Cisplatin
Sponsors:   Northwell Health;   Katie Oppo Foundation
Not yet recruiting
https://ift.tt/2L9kvq0